- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05912088
Elderly Falls Prevention With sLiFE Program in Primary Care
October 16, 2023 updated by: Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Effectiveness of the sLiFE Program to Reduce Falls and Frailty in Elderly People in Primary Care. Randomized Clinical Trial
This study aims to guide older people living in the community on appropriate strategies within a fall prevention program.
This program is aimed at training in daily activities carried out through group workshops (guided by a physiotherapist) and at preventing risk situations at home.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Two-arm, non-blind, non-inferiority experimental design. Multicenter, randomized trial.
The study tries to assess whether a group intervention following the principles of the sLiFE program is more effective than an usual health advice reducing the incidence of falls.
Study Type
Interventional
Enrollment (Estimated)
650
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emiliano Rodríguez-Sánchez, Dr
- Phone Number: 923231859
- Email: emiliano@usal.es
Study Contact Backup
- Name: Luis García-Ortiz, Dr
- Phone Number: 635542886
- Email: lgarciao@usal.es
Study Locations
-
-
-
Salamanca, Spain, 37005
- Recruiting
- Primary Care Research Unit of Salamanca (APISAL)
-
Contact:
- Ines Llamas, Dra
- Phone Number: 54750 923 291100
- Email: inesllamas@usal.es
-
Contact:
- Emiliano Rodriguez, Dr
- Phone Number: 54750 923 291100
- Email: Emiliano@usal.es
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- People older than 65 years of age
- Living at home
- Speak and read Spanish
Exclusion Criteria:
- Heart failure (NYHA class III and IV)
- Recent stroke (<6 months)
- Parkinson's disease
- In active cancer treatment (last 6 months)
- GOLD class III and IV chronic obstructive pulmonary disease
- Unstable lower extremity fracture
- Amputated lower extremity
- Treatment less than 6 months of depression
- Uncontrolled resting blood pressure of a systolic > 160 or diastolic > 100 or more
- Unavailability for intervention, planned travel or relocation more than 2 months within the first 6 months of the study
- Moderate to severe cognitive impairment (Mini Mental cognitive assessment <23)
- Current participation in another interventional clinical trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
The strength and balance activities of the sLiFE program will be carried out.
Participants will be invited to participate in groups of about 14 people in Primary Care Heath Centers.
|
Subjects will participate in groups of about 14 to implement the program.
|
|
Placebo Comparator: Control Group
Participants will receive the usual health advice.
|
Subjects will receive the usual care advice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health effects
Time Frame: 6 months
|
It will be measured using the quality of life questionnaire EQ-5D
|
6 months
|
|
Incidence of falls
Time Frame: 6 months
|
Number of falls in relation to the degree of physical activity.
|
6 months
|
|
Physical activity
Time Frame: 8 days
|
It will be evaluated with a digital pedometer for 9 consecutive days
|
8 days
|
|
Physical activity
Time Frame: 6 months
|
It will be evaluated with the Global Physical Activity Questionnaire
|
6 months
|
|
Frailty
Time Frame: 6 months
|
Frailty will be measured according to the five criteria of Fried's phenotype: 1) Low muscle strength; 2) Poor nutrition; 3) Poor endurance; 4) Slow walking and 5) Low physical activity.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fear of falling
Time Frame: 6 months
|
It will be assesses using the Short Falls International Scale of Efficacy (Short FES I).
It measures of "concerns about falling".
This scale has 7 items with a Likert scale with 4 options: 1) not at all concerned, 2) somewhat concerned, 3) fairly concerned, and 4) very concerned.
|
6 months
|
|
Cognitive assessment
Time Frame: 6 months
|
It will be evaluated with the Montreal Cognitive Assessment (MoCA): 30 questions and takes 10-12 minutes to complete.
|
6 months
|
|
Motor function
Time Frame: 6 months
|
It will be evaluated with the Short Physical Performance Battery (SPPB).
It assesses three aspects of mobility: balance, gait speed and strength of limbs or lower limbs to get up from a chair
|
6 months
|
|
Adherence to exercise
Time Frame: 6 months
|
It will be assessed using the Exercise Adherence Rating Scale (EARS).
It is composed of 16 items scored using a 5-point Likert scale (0 = completely agree to 4 = completely disagree) with a possible summed score range from 0 to 64.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Luis García-Ortiz, Dr, Primary Health Care Research Unit
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2023
Primary Completion (Estimated)
July 1, 2024
Study Completion (Estimated)
July 31, 2025
Study Registration Dates
First Submitted
June 11, 2023
First Submitted That Met QC Criteria
June 11, 2023
First Posted (Actual)
June 22, 2023
Study Record Updates
Last Update Posted (Actual)
October 18, 2023
Last Update Submitted That Met QC Criteria
October 16, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GRS 2502/B/22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
McMaster UniversityRecruitingFrailty | Frailty Syndrome | Frail Older Adults | Frailty in AgingCanada
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain
-
University of IcelandLandspitali University HospitalRecruitingFrailty Syndrome | Elective Surgery | Frailty in Adult SurgeryIceland
-
University of NottinghamRecruitingFrailty | Diet | Systemic Inflammatory Response | Dietary Fiber | Frailty at Older Adults | Pre-FrailtyUnited Kingdom
-
Maximilian KönigNot yet recruiting
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
-
Xijing HospitalEnrolling by invitationFrailty SyndromeChina
-
Longeveron Inc.CompletedAging FrailtyUnited States
Clinical Trials on Intervention Group
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...Active, not recruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium
-
Beijing HospitalThe First Hospital of Jilin University; Jilin University; Chinese Academy of...Not yet recruitingAsthma | Allergic Disease
-
Hospital de Clinicas de Porto AlegreUnknown
-
University of California, San FranciscoNational Cancer Institute (NCI); Cancer Prevention Institute of CaliforniaCompletedHereditary Breast and Ovarian Cancer Syndrome
-
University of Sao PauloCompletedAnxiety | Self Esteem
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Salubris (Suzhou) Pharmaceutical Co., Ltd.RecruitingPostmenopausal Women With OsteoporosisChina
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom